NCODA Logo

Selpercatinib (Retevmo®) Management

Written By: Joshua Nubla, PharmD, NCODA Download Here Description: This PQI is developed to provide guidance for management of patients treated with selpercatinib. Background: Selpercatinib is a kinase inhibitor indicated for the treatment of: Adult patients with...